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NEPHROTOXICITY OF CONCOMITANT ADMINISTRATION OF TACROLI-
MUS AND NEPHROTOXIC ANTIMICROBIAL AGENTS (AMINOGLYCOSIDES
AND GLYCOPEPTIDES) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Mori, T., Kato, J., Yamane, A., Okamoto, S. Keio University School of
Medicine, Tokyo, Japan
Background: Tacrolimus has been widely used for the prophylaxis
or treatment of graft-versus-host disease (GVHD) after allogeneic
hematopoietic stem cell transplantation (allo-HSCT). Nephrotoxi-
city is one of its most important toxicities. Recipients of all-HSCT
are highly susceptible to infectious complications and are often
treated with nephrotoxic antimicrobial agents such as aminoglyco-
sides (AGs) and glycopeptides (GPs). Since nephrotoxicity of con-
comitant use of tacrolimus and these nephrotoxic agents has yet to
be fully and systematically evaluated, we retrospectively evaluated
it in the recipients of allo-HSCT.
Patients &Methods: Recipients of allo-HSCT who received in-
travenous AGs or GPs during the continuous intravenous infu-
sion of tacrolimus within 30 days after transplantation were
selected from the data base and 50 patients were included. Pa-
tients who received liposomal amphotericin-B or foscarnet were
excluded. The data including patient characteristics, whole blood
concentration of tacrolimus, dose and duration of AG/GP treat-
ment, and serum creatinine (sCr) were evaluated. Therapeutic
drug monitoring of AGs, GPs, and tacrolimus was performed
in all the patients.
Results: Median age of the patients was 47.5 years (range: 18-60)
and diagnoses were all hematological diseases. In the 50 patients,
there were 40 episodes of tacrolimus concomitant with AGs (amika-
cin, gentamicin, arbekacin) and 38 with GPs (teicoplanin, vancomy-
cin). Median duration of the concomitant administration with
tacrolimus was 8 days (range: 2-22) for AGs and 11.5 days (range:
4-40) for GPs. Mean blood concentrations of tacrolimus during
AG and GP administration were 17.162.1 and 16.261.6 mg/ml, re-
spectively. Twice or greater increases of sCr compared with that be-
fore initiating AGs or GPs were observed only in 2 of 40 (5.0%)
episodes with AGs and 1 of 38 (2.8%) with GPs. Nephrotoxicity
was reversible and manageable in all cases and no patient required
hemodialysis.
Conclusion: Concomitant administration of tacrolimus and AGs or
GPs is feasible even in the early post-transplant period.However, ap-
propriate management with therapeutic drug monitoring for each
agent is essential.321
FACTORS ASSOCIATED WITH THE AVOIDANCE OF RED CELL TRANSFU-
SION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kekre, N.1, Christou, G.1, Mallick, R.3, Tokessy, M.2, Tinmouth, A.1,
Tay, J.1, Allan, D.1,4 1University of Ottawa, Ottawa, ON, Canada;
2The Ottawa Hospital, Ottawa, ON, Canada; 3Ottawa Hospital Research
Institute, Ottawa, ON, Canada; 4Ottawa, ON, Canada
Background: Red blood cell (RBC) transfusion is required fre-
quently for most patients following hematopoietic stem cell trans-
plantation (HSCT). RBC transfusion, however, can be associated
with adverse events including transfusion reactions, acquiring trans-
missible disease and delayed recovery. Factors associated with avoid-
ance of transfusion are not well documented.
Study Design and Methods: Data concerning RBC transfusions
between day 0 and day +30 were analyzed for patients undergoing
HSCT at a single Canadian transplant centre between January
2002 and December 2007.Results: Of 555 patients undergoing HSCT with complete RBC
transfusion data, 59 patients (10.6%) did not require RBC trans-
fusion in the first 30 days after HSCT. Univariate analysis showed
no significant difference in age, graft source or conditioning reg-
imen between transfused compared with non-transfused patients.
Factors that were significantly associated with avoidance of trans-
fusion included male gender (p 5 0.0013), diagnosis (p\ 0.0001),
early stage disease (p 5 0.006) and higher baseline haemoglobin
(Hb) at time of transplant (p\ 0.0001). In multivariate analysis,
higher pre-transplant Hb, OR 9.73 (4.11, 23.02), and early stage
disease, OR 2.24 (1.05, 4.76), remained significantly associated
with avoidance of RBC transfusion. The degree of RBC transfu-
sion correlates with the pre-transplant Hb value (r 5 - 0.89). In
particular, a pre-transplant hemoglobin level of 114 g/L or
greater was most strongly associated with the avoidance of RBC
transfusion.
Conclusion: Increased pre-transplant Hb and early stage disease are
associated with avoidance of RBC transfusion afterHSCT. Interven-
tions aimed at improving pre-transplant hemoglobin levels require
further study.CRP–DATA MANAGEMENT322
PART-TIME EMPLOYMENT OF GRADUATE STUDENTS FOR CIBMTR DATA
SUBMISSION IS HIGHLY EFFICIENT AND MUTUALLY ADVANTAGEOUS
Rudolph, S., Salzman, D., Gazi, M., Vaughan, W.P., Koralkar, R. Uni-
versity of Alabama at Birmingham, Birmingham, AL
The Bone Marrow Transplantation & Cellular Therapy Program
and the School of PublicHealth,Department of Epidemiology at the
University of Alabama at Birmingham, has partnered with first year
Master candidates for completion and submission of stem cell recip-
ients’ CIBMTR forms. Both the transplant program and the students
have benefited from this collaboration.
Resource Management: The Adult Program averages 100 trans-
plant patients per year and this requires 2 full-time equivalents for
timely completion of CIBMTR forms. In this capacity, the Program
currently employs 1 full-time equivalent. The second position em-
ploys a Graduate Student Assistant in an irregular part-time position
without benefits, and performs identical data retrieval and entry
duties.
Time Utilization: The Graduate Student Assistant’s time is
scheduled around their classes with both morning and evening
work hours available. This schedule can be easily accommodated
as the School of Public Health is located only three blocks from
the Hospital.
Benefits: Benefits for the students exceed simple financial compen-
sation and are outlined below. Likewise the transplant program ben-
efits from these highly motivated individuals.
Student-
$ Financial pay comparative to entry level FTE
$ Potential internships within UAB Hospital
$ Project management skills attained
$ Data analysis skills
$ Process improvement participation
$ Abstracts/Publications
$ Easy accessibility between work and school
$ Program Director recommendation for desired careers (exam-
ples include staff epidemiologists, dental school and other doctorate
programs)
Program-
$ Medically knowledgeable
$ Cost savings-full-time vs. irregular part time without benefits
$ Data analysis assistance
$ Research assistance
$ Enhanced computer skills of a master level student
$ Generally highly efficient and goal oriented employees
Future Goals: Exit interviews to survey students’ satisfaction, ed-
ucational benefits and skills enhancement.
